Eldridge Investment Advisors Inc. Has $2.25 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Eldridge Investment Advisors Inc. lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,147 shares of the exchange traded fund’s stock after selling 1,765 shares during the quarter. Eldridge Investment Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,245,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Commonwealth Equity Services LLC increased its stake in shares of SPDR S&P Biotech ETF by 58.1% in the third quarter. Commonwealth Equity Services LLC now owns 195,033 shares of the exchange traded fund’s stock valued at $14,241,000 after buying an additional 71,658 shares during the period. Kingswood Wealth Advisors LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 85.0% during the 3rd quarter. Kingswood Wealth Advisors LLC now owns 6,315 shares of the exchange traded fund’s stock worth $461,000 after buying an additional 2,901 shares in the last quarter. Pinnacle Associates Ltd. grew its position in shares of SPDR S&P Biotech ETF by 35.0% during the 3rd quarter. Pinnacle Associates Ltd. now owns 7,761 shares of the exchange traded fund’s stock worth $567,000 after buying an additional 2,010 shares during the period. Avaii Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at $268,000. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $102,900,000.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock traded up $1.11 on Thursday, hitting $88.44. The company had a trading volume of 7,087,503 shares, compared to its average volume of 11,666,752. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The stock has a 50 day moving average of $92.28 and a 200-day moving average of $85.06. The stock has a market capitalization of $6.74 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.